NYSE · SIC 3826
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, and genetic data management.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.3B | $6.3B | $6.8B | $6.8B | $6.5B | $6.9B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $846.0M | $1.3B | $1.6B | $1.4B | $1.5B | $1.5B |
| Net income | $719.0M | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B |
| Diluted EPS | $2.30 | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Operating cash flow | $921.0M | $1.5B | $1.3B | $1.8B | $1.8B | $1.6B |
| Free cash flow | $802.0M | $1.3B | $1.0B | $1.5B | $1.4B | $1.2B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 15.8% | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Net margin | 13.5% | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% |
| Line item | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.7B | $1.7B | $1.7B | $1.7B | $1.9B | $1.8B | $1.8B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $333.0M | $408.0M | $376.0M | $300.0M | $360.0M | $443.0M | $353.0M | $399.0M |
| Net income | $282.0M | $351.0M | $318.0M | $215.0M | $336.0M | $434.0M | $305.0M | $339.0M |
| Diluted EPS | $0.97 | $1.23 | $1.11 | $0.75 | $1.18 | $1.53 | $1.07 | $1.20 |
| Operating cash flow | $452.0M | $481.0M | $431.0M | $221.0M | $362.0M | $545.0M | $268.0M | $277.0M |
| Free cash flow | $360.0M | $388.0M | $334.0M | $107.0M | $259.0M | $452.0M | $175.0M | $201.0M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 21.1% | 24.0% | 22.4% | 18.0% | 20.7% | 23.8% | 19.6% | 21.7% |
| Net margin | 17.9% | 20.6% | 18.9% | 12.9% | 19.3% | 23.3% | 17.0% | 18.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | KIRKWOOD JONAH PREVOST· Senior Vice President | Tax withholding | 30 | $136.01 | $4,080.30 | filing |
| 2026-06-03 | MCDONNELL PADRAIG· President and CEO | Tax withholding | 418 | $137.40 | $57,433.20 | filing |
| 2026-05-29 | Dolsten Mikael | Sale | 1,600 | $135.42 | $216,672.00 | filing |
| 2026-05-19 | Buckner Michael Steven· Senior Vice President | Award | 8,872 | $0.00 | $0.00 | filing |
| 2026-05-08 | MAY SIMON· Senior Vice President | Tax withholding | 368 | $115.62 | $42,548.16 | filing |
| 2026-03-31 | Henson Meghan· Senior Vice President | Tax withholding | 153 | $113.98 | $17,438.94 | filing |
| 2026-03-19 | Dolsten Mikael | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | Rataj Sue H. | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | BRAWLEY OTIS W | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | SCANGOS GEORGE A | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | Soriot Pascal | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | WILSON DOW R | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | Podolsky Daniel K | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | KOH BOON HWEE | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | Brown Judy L | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | Anand Mala | Award | 2,158 | $111.75 | $241,156.50 | filing |
| 2026-03-19 | SCANGOS GEORGE A | Award | 1,057 | $111.75 | $118,119.75 | filing |
| 2026-03-19 | BRAWLEY OTIS W | Award | 888 | $111.75 | $99,234.00 | filing |
| 2026-03-19 | Soriot Pascal | Tax withholding | 648 | $111.75 | $72,414.00 | filing |
| 2026-03-19 | KOH BOON HWEE | Tax withholding | 648 | $111.75 | $72,414.00 | filing |
| 2026-02-27 | MCDONNELL PADRAIG· President and CEO | Tax withholding | 279 | $121.38 | $33,865.02 | filing |
| 2026-02-27 | KIRKWOOD JONAH PREVOST· Senior Vice President | Tax withholding | 124 | $121.38 | $15,051.12 | filing |
| 2026-02-27 | RIEMANN ANGELICA· Senior Vice President | Tax withholding | 89 | $121.38 | $10,802.82 | filing |
| 2025-12-01 | Dolsten Mikael | Sale | 2,600 | $149.81 | $389,511.20 | filing |
| 2025-11-26 | Gonsalves Rodney· V.P., Corporate Controller | Sale | 3,000 | $154.99 | $464,955.90 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.